Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Relationship Between Neuropsychological Testing and MRI, PET and Blood Biomarkers in Neurodegenerative Disease (COBRE - Project 1): AIM 2
Authors not listed
Aaron Ritter, MD · 2018
Abstract
The complex pathological cascades leading to both Alzheimer's disease (AD) and Parkinson's disease (PD) involve, at various points, inflammation. Since inflammation is a treatable symptom, understanding how and when it impacts the brain, and where specifically in the brain, would offer important guidance in the development of new treatments, sorely needed in both diseases.
Microglia play an important anti-inflammatory role, and produce a substance, mitochondrial translocator protein (TSPO), whose presence can be used as a marker of regional inflammation. GE180 is a newly developed PET ligand which binds to TSPO and hence can be used in imaging studies to analyze regional inflammation in living patients. In prior studies it has shown regional specificity in multiple sclerosis and brain injury. In the current study, the investigators will be using GE180 to analyze regional and global inflammation in the brains of patients with AD and PD at a single time point.
The results of the current study will provide enriched understanding of inflammation in these conditions, and potentially provide preliminary data to inform design of future interventional trials.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Anonymous. (2018). The Relationship Between Neuropsychological Testing and MRI, PET and Blood Biomarkers in Neurodegenerative Disease (COBRE - Project 1): AIM 2. <em>Aaron Ritter, MD</em>. https://clinicaltrials.gov/study/NCT03702816
Vancouver
Anonymous. The Relationship Between Neuropsychological Testing and MRI, PET and Blood Biomarkers in Neurodegenerative Disease (COBRE - Project 1): AIM 2. Aaron Ritter, MD. 2018.
BibTeX
@misc{anon2018TheRel,
title = {The Relationship Between Neuropsychological Testing and MRI, PET and Blood Biomarkers in Neurodegenerative Disease (COBRE - Project 1): AIM 2},
author = {Anonymous},
journal = {Aaron Ritter, MD},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Adelaide Research & Scholarship (AR&S) (University of Adelaide) 2024
Preprint · OA
Exploring Microglial Ageing: Insights from Human Genomic Data, Pre-Clinical Animal Models, and the Future of In Vitro Modelling
African Health Sciences 2019
Open access · CC-BY
Association of inflammatory biomarkers with lung cancer in North Indian population
Proteomes 2016
Open access · CC-BY
The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer’s Disease
Neurobiology of aging 2027
Citation only
The effect of neurodegeneration on ultrasonic vocalisations (USV) and their neuronal substrates in mice and rats: A systematic review.
University of Pennsylvania 2017
Open access · US-GOV
Tau PET Imaging in the NACC Study Cohort: Modulators of MTL Subregion Structure and Function in Normal and Pathological Aging
Allergologia et Immunopathologia 2014
Open access · OA